John McLaren-Howard: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(cat) |
Notjusttired (talk | contribs) m (Text replacement - " \|" to " |") |
||
| Line 36: | Line 36: | ||
==Notable studies== | ==Notable studies== | ||
* 2009, Chronic fatigue syndrome and mitochondrial dysfunction<ref name="Myhill2009">{{citation | * 2009, Chronic fatigue syndrome and mitochondrial dysfunction<ref name="Myhill2009">{{citation | ||
| last1 = Myhill | first1 = S | | last1 = Myhill | first1 = S | authorlink1 = Sarah Myhill | ||
| last2 = Booth | first2 = NE | | last2 = Booth | first2 = NE | authorlink2 = Norman Booth | ||
| last3 = McLaren-Howard | first3 = J | | last3 = McLaren-Howard | first3 = J | authorlink3 = John McLaren-Howard | ||
| title = Chronic fatigue syndrome and mitochondrial dysfunction | | title = Chronic fatigue syndrome and mitochondrial dysfunction | ||
| journal = International Journal of Clinical Experimental Medicine | volume = 2| issue = 1| pages = 1–16 | | journal = International Journal of Clinical Experimental Medicine | volume = 2| issue = 1| pages = 1–16 | ||
| Line 46: | Line 46: | ||
}}</ref> | }}</ref> | ||
* 2012, Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref name="Booth2012">{{citation | * 2012, Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref name="Booth2012">{{citation | ||
| last1 = Booth | first1 = NE | | last1 = Booth | first1 = NE | authorlink1 = Norman Booth | ||
| last2 = Myhill | first2 = S | | last2 = Myhill | first2 = S | authorlink2 = Sarah Myhill | ||
| last3 = McLaren-Howard | first3 = J | | last3 = McLaren-Howard | first3 = J | authorlink3 = John McLaren-Howard | ||
| title = Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | | title = Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | ||
| journal = International Journal of Clinical Experimental Medicine | volume = 5| issue = 3| pages = 208–220 | | journal = International Journal of Clinical Experimental Medicine | volume = 5| issue = 3| pages = 208–220 | ||
| Line 56: | Line 56: | ||
}}</ref> | }}</ref> | ||
* 2013, Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit<ref name="Myhill2013">{{citation | * 2013, Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit<ref name="Myhill2013">{{citation | ||
| last1 = Myhill | first1 = S | | last1 = Myhill | first1 = S | authorlink1 = Sarah Myhill | ||
| last2 = Booth | first2 = NE | | last2 = Booth | first2 = NE | authorlink2 = Norman Booth | ||
| last3 = McLaren-Howard | first3 = J | | last3 = McLaren-Howard | first3 = J | authorlink3 = John McLaren-Howard | ||
| title = Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit | | title = Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit | ||
| journal = International Journal of Clinical Experimental Medicine | volume = 6| issue = 1| pages = 1–15 | | journal = International Journal of Clinical Experimental Medicine | volume = 6| issue = 1| pages = 1–15 | ||
Revision as of 05:41, May 11, 2022
John McLaren-Howard, DSc,[1] is the director of the Acumen Medical Limited, a laboratory in Devon, UK.[2] He is a Fellow of the American College of Nutrition.[1]
He was a co-author of the publication "Myalgic Encephalomyelitis – Adult & Paediatric: International Consensus Primer for Medical Practitioners," following the 2012 publication of the 2012 International Consensus Criteria (and co-written with many of the same authors of the latter).[1]
Notable studies[edit | edit source]
- 2009, Chronic fatigue syndrome and mitochondrial dysfunction[3]
- 2012, Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[4]
- 2013, Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit[5]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, ACP; Speight, N; Vallings, R; Bateman, L; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Gerken, A; Jo, D; Lewis, DP; Light, AR; Light, KC; Marshall-Gradisnik, S; McLaren-Howard, J; Mena, I; Miwa, K; Murovska, M; Stevens, SR (2012), Myalgic encephalomyelitis: Adult & Paediatric: International Consensus Primer for Medical Practitioners (PDF), ISBN 978-0-9739335-3-6
- ↑ "Acumen Medical Limited". www.cqc.org.uk. Retrieved January 21, 2019.
- ↑ Myhill, S; Booth, NE; McLaren-Howard, J (January 15, 2009), "Chronic fatigue syndrome and mitochondrial dysfunction", International Journal of Clinical Experimental Medicine, 2 (1): 1–16, PMID 19436827
- ↑ Booth, NE; Myhill, S; McLaren-Howard, J (June 15, 2012), "Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)", International Journal of Clinical Experimental Medicine, 5 (3): 208–220, PMID 22837795
- ↑ Myhill, S; Booth, NE; McLaren-Howard, J (2013), "Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit", International Journal of Clinical Experimental Medicine, 6 (1): 1–15, PMID 23236553
 | This article is a stub. |
